Skip to content

In the BioHarmony Drug Report Database

Molindone

Moban (molindone) is a small molecule pharmaceutical. Molindone was first approved as Moban on 1982-01-01. It is used to treat psychotic disorders, schizophrenia, and schizophrenia spectrum and other psychotic disorders in the USA. The pharmaceutical is active against 5-hydroxytryptamine receptor 2A. In addition, it is known to target histamine H1 receptor.
Trade Name Moban
Common Name Molindone
Indication psychotic disorders, schizophrenia, schizophrenia spectrum and other psychotic disorders
Drug Class Typical antipsychotic
Molindone
Get full access now